Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety and efficacy of a subcutaneous injection of nL-SAA1-01in a patient with AA Amyloidosis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06397001
Study type Interventional
Source Mayo Clinic
Contact
Status Active, not recruiting
Phase Phase 1
Start date November 28, 2023
Completion date January 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06354322 - Unclassified GENotypes of Autoinflammatory Diseases and AA Amyloidosis
Completed NCT02704065 - Recurrent AA Amyloidosis After Renal Transplantation N/A